ストックスクリーナーアプリを入手
3.49
2.79%
-0.10
プレマーケット:
3.50
0.010
+0.29%
前日終値:
$3.59
開ける：
$3.5
24時間の取引高:
543.82K
Relative Volume:
1.10
時価総額：
$130.78M
収益：
$425.17M
当期純損益:
$-92.21M
株価収益率:
-1.358
EPS:
-2.57
ネットキャッシュフロー:
$-67.42M
1週間 パフォーマンス:
-5.93%
1か月 パフォーマンス:
-19.77%
6か月 パフォーマンス:
-54.14%
1年 パフォーマンス:
-83.21%
1日の値動き範囲:
$3.42
$3.59
1週間の範囲:
$3.42
$3.985
52週間の値動き範囲:
$3.42
$21.00
Nevro Corp Stock (NVRO) Company Profile
NVRO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NVRO
Nevro Corp
|
3.49 | 130.78M | 425.17M | -92.21M | -67.42M | -2.57 |
|
ABT
Abbott Laboratories
|
114.25 | 198.16B | 41.22B | 5.77B | 6.49B | 3.29 |
|
BSX
Boston Scientific Corp
|
95.95 | 141.41B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
364.10 | 138.80B | 21.97B | 3.59B | 3.21B | 9.33 |
|
MDT
Medtronic Plc
|
82.68 | 106.02B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
74.15 | 43.73B | 6.60B | 4.16B | 490.10M | 6.93 |
Nevro Corp Stock (NVRO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-03 | 開始されました | Wells Fargo | Equal Weight |
| 2024-12-02 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2024-08-09 | アップグレード | Citigroup | Sell → Neutral |
| 2024-08-08 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2024-08-07 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-07 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2024-08-07 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2024-05-22 | ダウングレード | Citigroup | Neutral → Sell |
| 2024-02-22 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2024-01-12 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-12-21 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2023-07-19 | 開始されました | Robert W. Baird | Neutral |
| 2023-05-31 | 開始されました | RBC Capital Mkts | Outperform |
| 2023-05-15 | アップグレード | Oppenheimer | Perform → Outperform |
| 2023-04-14 | 開始されました | Mizuho | Neutral |
| 2023-01-17 | ダウングレード | Citigroup | Buy → Neutral |
| 2023-01-06 | ダウングレード | Piper Sandler | Neutral → Underweight |
| 2022-12-20 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2022-12-12 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-10-12 | 開始されました | Jefferies | Underperform |
| 2022-05-05 | アップグレード | Citigroup | Neutral → Buy |
| 2022-04-13 | 再開されました | Truist | Hold |
| 2022-04-06 | 開始されました | Wolfe Research | Underperform |
| 2022-03-02 | 再開されました | BofA Securities | Underperform |
| 2022-01-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-06 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2021-11-09 | ダウングレード | Truist | Buy → Hold |
| 2021-08-05 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2021-08-05 | ダウングレード | Citigroup | Buy → Neutral |
| 2021-08-05 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-08-05 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2021-08-05 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2021-07-09 | ダウングレード | Redburn | Buy → Neutral |
| 2021-07-06 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2021-02-02 | 開始されました | Piper Sandler | Overweight |
| 2020-10-23 | 開始されました | Guggenheim | Buy |
| 2020-09-02 | 開始されました | Robert W. Baird | Outperform |
| 2020-06-08 | アップグレード | UBS | Sell → Neutral |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2020-02-26 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2020-01-08 | 開始されました | SunTrust | Buy |
| 2020-01-06 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2019-11-07 | アップグレード | Oppenheimer | Perform → Outperform |
| 2019-10-22 | 開始されました | Oppenheimer | Perform |
| 2019-03-20 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-03-20 | アップグレード | Wells Fargo | Market Perform → Outperform |
| 2018-11-28 | 開始されました | UBS | Sell |
| 2018-11-07 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2018-11-06 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2018-11-06 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2018-10-19 | ダウングレード | Goldman | Neutral → Sell |
| 2018-07-02 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2018-05-08 | 繰り返されました | Canaccord Genuity | Buy |
| 2018-05-08 | ダウングレード | Northland Capital | Outperform → Market Perform |
| 2018-05-08 | ダウングレード | Wells Fargo | Outperform → Market Perform |
すべてを表示
Nevro Corp (NVRO) 最新ニュース
Nevro stock plunges to 52-week low at $3.51 amid market challenges - Investing.com
Nevro stock plunges to 52-week low at $3.51 amid market challenges By Investing.com - Investing.com South Africa
Director Weatherman Elizabeth H was granted 5,325 shares, increasing direct ownership by 7% to 86,171 units (SEC Form 4) - Quantisnow
State Street Corp Has $4.21 Million Position in Nevro Corp. (NYSE:NVRO) - MarketBeat
What Makes Nevro (NVRO) a New Buy Stock - Yahoo Finance
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 - The Eastern Progress Online
Nevro price target lowered to $4.70 from $7 at Truist - Yahoo Finance
Where Nevro Stands With Analysts - Benzinga
Truist Financial Has Lowered Expectations for Nevro (NYSE:NVRO) Stock Price - MarketBeat
Nevro announces new inducement grants - Medical Buyer
Nevro Corp. (NYSE:NVRO) Receives $8.05 Consensus Target Price from Analysts - MarketBeat
Here's Why You Should Retain Nevro Stock In Your Portfolio Now - Barchart
Nevro shares price target cut, neutral stance held on potential By Investing.com - Investing.com South Africa
Nevro shares price target cut, neutral stance held on potential - Investing.com
Here's Why you Should Retain Nevro Stock in Your Portfolio Now - Nasdaq
Nevro Corp (NVRO) PT Lowered to $6 at Mizuho - StreetInsider.com
Nevro Corp's SWOT analysis: stock faces headwinds amid market challenges - Investing.com India
Nevro stock plunges to 52-week low, touches $3.95 By Investing.com - Investing.com South Africa
Nevro stock plunges to 52-week low, touches $3.95 - Investing.com
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 566,462 Shares of Nevro Corp. (NYSE:NVRO) - MarketBeat
Zacks.com featured highlights include Stryve Foods, Nevro, Canoo, MSA Safety and VTEX - Yahoo Finance
Bet on 5 Top-Ranked Stocks With Rising P/E - Yahoo Finance
Jacobs Levy Equity Management Inc. Buys 246,979 Shares of Nevro Corp. (NYSE:NVRO) - MarketBeat
Nevro Announces the Launch of HFX AdaptivAI™, the Only AI-Driven Technology in Spinal Cord Stimulation - The Eastern Progress Online
Western Standard LLC Makes New $5.47 Million Investment in Nevro Corp. (NYSE:NVRO) - MarketBeat
Shay Capital LLC Increases Stake in Nevro Corp: A Strategic Move Amidst Financial Challenges - GuruFocus.com
Nevro Corp's SWOT analysis: stock faces headwinds amid SCS market challenges - Investing.com Canada
Nevro Corp's SWOT analysis: stock faces headwinds amid SCS market challenges By Investing.com - Investing.com South Africa
SVP, Chief Financial Officer Macleod Roderick H. covered exercise/tax liability with 816 shares, decreasing direct ownership by 0.61% to 133,118 units (SEC Form 4) - Quantisnow
SVP, Chief Operating Officer Christoforou Christofer covered exercise/tax liability with 583 shares, decreasing direct ownership by 0.42% to 138,399 units (SEC Form 4) - Quantisnow
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos - AOL
Morgan Stanley Maintains Positive MedTech Outlook… - Inkl
Morgan Stanley slashes Nevro stock target, flags SCS struggles and strategic challenges - Investing.com Canada
What Analysts Are Saying About Nevro Stock - Inkl
Morgan Stanley slashes Nevro stock target, flags SCS struggles and strategic challenges By Investing.com - Investing.com South Africa
Nevro (NYSE:NVRO) Downgraded to "Underweight" Rating by Morgan Stanley - MarketBeat
Morgan Stanley Downgrades Nevro Corp (NVRO) to Underweight - StreetInsider.com
Nevro downgraded to Underweight from Equal Weight at Morgan Stanley - TipRanks
Fred Alger Management LLC Has $93,000 Holdings in Nevro Corp. (NYSE:NVRO) - MarketBeat
Nevro (NVRO) Shares Outstanding (EOP) : 37.4 Mil (As of Sep. 2024) - GuruFocus.com
Engaged Capital LLC Has $13.66 Million Holdings in Nevro Corp. (NYSE:NVRO) - MarketBeat
NVRO Stock Declines Despite Positive Study Data of Nevro1 System - MSN
Nevro Corp. (NYSE:NVRO) Receives Average Recommendation of "Reduce" from Brokerages - MarketBeat
Nevro Corp (NVRO) 財務データ
収益
当期純利益
現金流量
EPS
1.54%
1.42%
大文字化:
|
ボリューム (24 時間):